Brain Imaging Devices Market Size & Growth Forecast 2026–2035, By Segments (Product, Modality, End Use, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Brain Imaging Devices Market size was over USD 6.01 Billion in 2025 and is likely to grow at a 8.2% CAGR between 2026 and 2035, surpassing USD 13.22 Billion by 2035. The industry revenue for 2026 is assessed at USD 6.44 billion.
Get more details on this report
Request Free Sample ReportBrain Imaging Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America captured 41.55% of the market in 2025, supported by advanced hospitals, specialized diagnostic networks, strong imaging utilization, and established reimbursement and clinical infrastructure.
- Asia Pacific is projected to grow at a 9.27% CAGR as healthcare infrastructure expands, imaging installations increase, and more facilities adopt advanced diagnostic technologies for neurological care.
Segment Momentum
- Devices held a 77.43% share in 2025 because they form the core imaging platform used across hospitals and diagnostic centers, making them essential for routine clinical brain imaging workflows.
- Portable systems are growing fastest as healthcare providers seek flexible, point-of-care imaging that supports bedside assessments, faster decision-making, and improved access where patient movement is challenging.
Market Expansion Drivers
- Rising neurological disorder prevalence driving demand for advanced diagnostic brain imaging systems.
- AI-enabled portable imaging technologies improving accessibility and diagnostic efficiency.
- Government neurological health initiatives expanding diagnostic infrastructure and awareness programs.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Leading companies in the brain imaging devices market include GE HealthCare Technologies Inc. (United States), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Medtronic plc (Ireland), Nihon Kohden Corporation (Japan), Compumedics Limited (Australia), MEGIN Oy (Finland), Natus Medical Incorporated (United States), NeuroLogica Corporation (United States).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
As neurological conditions such as stroke, dementia, epilepsy, brain tumors, and neurodegenerative disorders become more frequently diagnosed, providers are under greater pressure to identify structural and functional abnormalities earlier and with higher precision. This is driving demand for the brain imaging devices market by pushing hospitals, specialty neurology centers, and diagnostic networks to invest in systems that support faster clinical decision-making, better lesion characterization, and more reliable monitoring over time. In practice, rising patient volumes increase scan utilization, justify equipment upgrades from legacy platforms, and strengthen purchasing decisions around advanced MRI, CT, PET, and hybrid imaging systems that can handle more complex neurological case loads.
AI-enabled portable imaging technologies improving accessibility and diagnostic efficiency
AI-enabled portable platforms are reshaping adoption patterns in the brain imaging devices market by extending imaging access beyond large tertiary facilities and reducing workflow bottlenecks that often delay diagnosis. When image acquisition, triage support, and preliminary interpretation are assisted by AI, smaller care settings and emergency environments can use portable systems more confidently, even where specialist availability is limited. This improves the practical value proposition of compact brain imaging devices by shortening time to assessment, supporting decentralized care delivery, and increasing market penetration in outpatient, rural, and point-of-care settings where conventional fixed installations are less feasible.
Government neurological health initiatives expanding diagnostic infrastructure and awareness programs
Public investment in neurological care pathways is supporting market development in the brain imaging devices market by linking awareness efforts with expanded diagnostic capacity. When governments fund stroke programs, cognitive health screening, hospital modernization, and regional diagnostic access, healthcare systems are more likely to procure imaging equipment, upgrade installed bases, and integrate brain imaging into standard referral protocols. Awareness campaigns also influence patient and physician behavior by encouraging earlier evaluation of neurological symptoms, which translates into higher imaging volumes and supports market expansion through more consistent use of diagnostic services.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising neurological disorder prevalence driving demand for advanced diagnostic brain imaging systems | 2.50% | High | North America, Europe | High | Near Term |
| AI-enabled portable imaging technologies improving accessibility and diagnostic efficiency | 2.20% | Moderate | North America, Asia Pacific | High | Mid Term |
| Government neurological health initiatives expanding diagnostic infrastructure and awareness programs | 1.60% | High | Europe, North America, Asia Pacific | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held the leading regional position in 2025, accounting for a 41.55% share of the brain imaging devices market. This leadership is sustained by the region’s dense concentration of advanced hospitals, academic medical centers, and specialized diagnostic networks that routinely invest in high-performance imaging systems. Strong integration of imaging into neurology, oncology, and emergency care workflows also supports steady equipment utilization and replacement demand, while established reimbursement structures and broad access to trained radiology and neurodiagnostic professionals help keep purchasing activity active across both large health systems and outpatient settings.
Asia Pacific is projected to expand at a 9.27% CAGR over the forecast period in the brain imaging devices market, driven by the practical spread of diagnostic infrastructure across rapidly developing healthcare systems. Growth is being accelerated by rising installation of imaging equipment in urban hospitals, expanding access to neurological assessment in large patient populations, and continued healthcare capacity building that increases the number of facilities able to adopt advanced diagnostic technologies. Demand is also benefiting from the shift toward earlier detection and more routine imaging-based evaluation, which is translating into higher equipment procurement across both public and private care environments.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Clinical Imaging PrecisionGermany emphasizes technologically advanced brain imaging devices that support accurate neurological diagnosis and clinical research. Healthcare institutions prioritize equipment with enhanced image quality, workflow optimization, and compatibility with multidisciplinary care environments.
France 🇫🇷
Neuroscience Research SupportFrance combines clinical neuroscience expertise with demand for advanced brain imaging technologies across healthcare and research institutions. Investment priorities include improved imaging performance, data interoperability, and expanded access to precision neurological diagnostics.
Italy 🇮🇹
Hospital Modernization DemandItaly continues upgrading diagnostic imaging infrastructure to strengthen neurological care across healthcare facilities. Demand favors brain imaging devices offering reliable performance, streamlined workflows, and compatibility with evolving hospital digital systems.
Japan 🇯🇵
Aging Care DiagnosticsJapan's brain imaging devices market is supported by growing demand for neurological assessment associated with an aging population. Healthcare providers increasingly adopt imaging technologies that enable earlier diagnosis and improved monitoring of complex neurological conditions.
South Korea 🇰🇷
AI Imaging AdoptionSouth Korea integrates brain imaging devices with digital healthcare initiatives and AI-enabled diagnostic platforms. Hospitals increasingly modernize imaging infrastructure to enhance diagnostic accuracy, operational efficiency, and support for advanced neurological care.
United States 🇺🇸
Advanced Diagnostic IntegrationThe U.S. brain imaging devices market benefits from ongoing adoption of advanced diagnostic technologies across hospitals and neuroscience centers. Healthcare providers increasingly invest in high-resolution imaging systems integrated with AI-assisted analysis to improve neurological assessment and clinical workflow efficiency.
Segment Leadership and Growth Trends
Brain Imaging Devices Market Share (%), Product, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportDevices held a 77.43% share of the brain imaging devices market in 2025, reflecting their central role in clinical imaging workflows and capital equipment purchasing. This leadership is sustained because diagnostic imaging depends primarily on the installed base of core systems used across hospitals, diagnostic centers, and specialized neurology settings. In the brain imaging devices market, these systems represent the essential platform for scan generation, making demand less discretionary than for supporting components and reinforcing the segment’s dominant share.
Accessories are the fastest-growing product segment in the brain imaging devices market as providers increasingly focus on improving system usability, workflow continuity, and application-specific performance without replacing full imaging platforms. Growth is gaining pace relative to devices because accessories can be adopted more quickly and at lower operational disruption, especially when facilities want to extend functionality, support higher procedure volumes, or adapt existing systems to evolving clinical requirements. This practical upgrade path is a key reason the segment is expanding faster than core equipment.
Modality Segment Analysis: Fixed (Largest Segment) vs Portable (Fastest-Growing Segment)
Within the brain imaging devices market, fixed systems accounted for the largest share in 2025 due to their established use in permanent clinical settings where imaging volume, infrastructure support, and standardized diagnostic workflows are concentrated. Their leadership is maintained by the fact that most advanced brain imaging procedures are still performed in hospitals and imaging centers built around dedicated rooms, specialized staff, and integrated equipment environments. That installed infrastructure continues to anchor fixed modality demand and preserves its leading share.
Portable systems are emerging as the fastest-growing modality in the brain imaging devices market because care delivery is expanding toward faster access, bedside assessment, and more flexible imaging deployment. The segment is gaining momentum over fixed alternatives where clinicians need mobility and quicker point-of-care decision support, particularly in settings where moving patients is difficult or time-sensitive evaluation is important. This operational advantage makes portable solutions increasingly attractive as healthcare providers look for more adaptable imaging workflows.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Devices, Accessories | Devices | Accessories |
| Modality | Fixed, Portable, Wearable | Fixed | Portable |
| End Use | Hospital, Diagnostic Imaging Centers, Ambulatory Surgery Centers, Others | Hospital | Diagnostic Imaging Centers |
| Application | Stroke, Brain Tumor, Traumatic Brain Injury (TBI), Epilepsy, Sleep Apnea, Headache, Structural Anomalies, Others | Brain Tumor | Epilepsy |
Competitive Landscape and Market Positioning
1. GE HealthCare Technologies Inc. (United States)
2. Siemens Healthineers AG (Germany)
3. Koninklijke Philips N.V. (Netherlands)
4. Canon Medical Systems Corporation (Japan)
5. Medtronic plc (Ireland)
6. Nihon Kohden Corporation (Japan)
7. Compumedics Limited (Australia)
8. MEGIN Oy (Finland)
9. Natus Medical Incorporated (United States)
10. NeuroLogica Corporation (United States)
Advancements in diagnostic precision are accelerating transformation in the brain imaging devices market. The brain imaging devices market is increasingly driven by integration of AI-enabled imaging analysis and high-resolution scanning technologies. Innovation is focused on improving diagnostic speed, accuracy, and clinical decision support capabilities.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Neurophet | Mar-24 | Neurophet presented AI-driven brain disorder analysis technologies at AD/PD 2024, including tools for predicting amyloid positivity and evaluating neurological conditions. The solutions are approaching commercialization and aim to enhance diagnostic and predictive capabilities in neurodegenerative disease assessment. |
| FUJIFILM India | Mar-24 | FUJIFILM India launched the Echelon Synergy MRI system during its CT & MRI User Conclave. The system enhances imaging performance through faster scan times and improved efficiency, strengthening FUJIFILM’s advanced MRI portfolio for neurological and general diagnostic applications. |
| Philips | Feb-24 | Philips and Synthetic MR launched Smart Quant Neuro 3D, an AI-enabled MRI analytics solution for brain disorders including MS, TBI, and dementia. The system improves tissue quantification and supports clinical decision-making, enhancing diagnostic precision and therapy monitoring in neurology imaging workflows. |
| Canon Medical Systems Ltd. | Nov-23 | Canon Medical Systems launched AI-enhanced CT imaging solutions at RSNA, including Aquilion ONE / INSIGHT Edition and Aquilion Serve SP. The systems are designed to support diagnosis of neurological disorders by improving imaging quality and workflow efficiency in advanced neuroimaging applications. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Brain Imaging Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Brain Imaging Devices Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchHow large is the brain imaging devices market?
How will the brain imaging devices industry grow in terms of size and CAGR by 2035?
How is rising neurological disorder prevalence influencing investment priorities in advanced brain imaging systems?
How are AI-enabled portable imaging systems changing deployment strategies in healthcare settings?
Why do Devices account for the largest share of the brain imaging devices market?
Why are Portable systems the fastest-growing modality in the brain imaging devices market?
Why does North America hold the largest share of the brain imaging devices market?
Which region is expected to experience the fastest growth in the brain imaging devices market?
Who holds a significant market share in the brain imaging devices landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization